Epstein–Barr Virus/Human Vector Provides High-Level, Long-Term Expression of α1-Antitrypsin in Mice
Open Access
- 31 August 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (2) , 122-129
- https://doi.org/10.1006/mthe.2001.0429
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Selective extraction of polyoma DNA from infected mouse cell culturesPublished by Elsevier ,2004
- Linear DNAs Concatemerize in Vivo and Result in Sustained Transgene Expression in Mouse LiverMolecular Therapy, 2001
- Inclusion of the Hepatic Locus Control Region, an Intron, and Untranslated Region Increases and Stabilizes Hepatic Factor IX Gene Expression in Vivo but Not in VitroMolecular Therapy, 2000
- Enhancement of Transgene Expression by Cotransfection of oriP Plasmid with EBNA-1 Expression VectorHuman Gene Therapy, 2000
- Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimerGene Therapy, 2000
- Sustained transgene expression in vitro and in vivo using an Epstein–Barr virus replicon vector system combined with HVJ liposomesGene Therapy, 1998
- Gene Therapy Strategies for Treating Epstein–Barr Virus-Associated Lymphomas: Comparison of Two Different Epstein–Barr Virus-Based VectorsHuman Gene Therapy, 1998
- The potential of extrachromosomal replicating vectors for gene therapyTrends in Genetics, 1996
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977